Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan

Pfizer28,511 enrolled

Overview

Streptococcus pneumoniae is a major cause of pneumonia, among infants and children in Japan and worldwideThis study plans to investigate the rate of invasive pneumococcal disease "IPD " and the rate of hospitalizations due to pneumonia in Okinawa and the Eastern half of Hokkaido Currently, only a limited information about pneumococcal disease burden is available in Japan.

Study Type

OBSERVATIONAL

Enrollment

28,511

Conditions

Pneumococcal Disease

Eligibility

Sex: ALLMin age: 28 DaysMax age: 60 Months

Medical Language ↔ Plain English

Eligibility Criteria \- Children residing in the surveillance area(s) aged 28 days to \<60 months with clinical suspicion of pneumonia, meningitis and bacteremia who were admitted to the hospital.

Locations (2)

Unnamed facility

Kushiro, Hokkaido, Japan

Unnamed facility

Naha, Okinawa, Japan

Outcomes

Primary Outcomes

1.Describe the distribution of causal pathogen of meningitis and bacteremia 2.Estimate the hospital admission rate of pneumonia patients 3.Estimate the incidence rate of IPD 4.Describe the serotype distribution of S. pneumoniae

Time frame: 2 years

Secondary Outcomes

1.CFRof patients admitted with IPD and/or pneumonia. 2.Antibiotic resistance rate of S. pneumoniae 3.Risk factor distribution 4.Average duration of the hospitalization of patients with IPD, meningitis, and/or pneumonia.

Time frame: 2-3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.